Erosive Esophagitis Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A Phase 2, Double Blind Study to Assess Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis (EE) and Maintenance of Healed EE in Pediatric Participants
Condition: Erosive EsophagitisInterventions: Drug: Dexlansoprazole; Drug: PlaceboSponsor: TakedaNot yet recruiting - verified December 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2015 Category: Research Source Type: clinical trials
To Evaluate Efficacy and Safety of Z-215 in Erosive Esophagitis
Condition: Esophagitis, RefluxInterventions: Drug: Z-215 10mg; Drug: Z-215 20mg; Drug: Z-215 Placebo; Drug: Rabeprazole Sodium; Drug: Rabeprazole Sodium PlaceboSponsor: Zeria PharmaceuticalRecruiting - verified June 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 2, 2015 Category: Research Source Type: clinical trials
Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis
Condition: Erosive EsophagitisInterventions: Drug: CJ-12420 100 mg QD; Drug: Esomeprazole 40 mg QDSponsor: CJ HealthCare CorporationRecruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2015 Category: Research Source Type: clinical trials
